Whitehawk Therapeutics Inc (NASDAQ: WHWK) open the trading on Thursday, with great promise as it jumped 12.84% to $1.67, before settling in for the price of $1.48 at the close. Taking a more long-term approach, WHWK posted a 52-week range of $1.21-$3.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 246.60% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 22.81%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 70.76%. This publicly-traded company’s shares outstanding now amounts to $46.78 million, simultaneously with a float of $31.93 million. The organization now has a market capitalization sitting at $78.13 million. At the time of writing, stock’s 50-day Moving Average stood at $1.9233, while the 200-day Moving Average is $2.1297.
Whitehawk Therapeutics Inc (WHWK) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Whitehawk Therapeutics Inc’s current insider ownership accounts for 31.74%, in contrast to 41.89% institutional ownership. According to the most recent insider trade that took place on Mar 03 ’25, this organization’s insider sold 2,147 shares at the rate of 2.35, making the entire transaction reach 5,045 in total value, affecting insider ownership by 102,853. Preceding that transaction, on Mar 03 ’25, Company’s CHIEF FINANCIAL OFFICER sold 2,806 for 2.35, making the whole transaction’s value amount to 6,594. This particular insider is now the holder of 23,944 in total.
Whitehawk Therapeutics Inc (WHWK) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
Whitehawk Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 70.76% and is forecasted to reach -1.08 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 22.70% through the next 5 years, which can be compared against the 22.81% growth it accomplished over the previous five years trading on the market.
Whitehawk Therapeutics Inc (NASDAQ: WHWK) Trading Performance Indicators
Let’s observe the current performance indicators for Whitehawk Therapeutics Inc (WHWK). It’s Quick Ratio in the last reported quarter now stands at 3.28. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.01.
In the same vein, WHWK’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.36, a figure that is expected to reach -0.46 in the next quarter, and analysts are predicting that it will be -1.08 at the market close of one year from today.
Technical Analysis of Whitehawk Therapeutics Inc (WHWK)
[Whitehawk Therapeutics Inc, WHWK] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 55.90% While, its Average True Range was 0.1176.
Raw Stochastic average of Whitehawk Therapeutics Inc (WHWK) in the period of the previous 100 days is set at 11.56%, which indicates a major fall in contrast to 73.68% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 70.25% that was lower than 93.84% volatility it exhibited in the past 100-days period.
